Abstract:Objective To study the cytotoxic effects of RGD-FasL on glioma cell lines U138/U373/U343 and the underlying mechanism. Methods Fas/DcR3 mRNA was detected by RT-PCR and its surface expression in the three cell lines was measured by flow cytometry analysis. Cytotoxicity exerted by RGD-FasL on glioma cell lines was measured with MTT assay and the induced apoptosis was determined by agarose gel electrophoresis. The cell cycle and apoptosis were assessed by flow cytometry with PI staining. The expressions of Caspase8/9/3 and Bcl-2 in cells were detected by Western blotting. Results Approximately 25.5 % of U138 cells,13.7% of U373 cells,and 13.9% of U343 cells expressed Fas,while about 22.2 % of U138 cells,15.5 % of U373 cells,and 23.4% of U343 cells expressed DcR3. The results were consistent with mRNA expressions of Fas and DcR3. Cell line U138 was sensitive to RGD-FasL in a dose-dependent manner; cell line U343 was partially sensitive to RGD-FasL; cell line U373 was sustained to RGD-FasL. The cell cycle analysis suggested that RGD-FasL could inhibit cells in G0/G1 phase and G2/M phase,thus inhibit cell growth. In U138 cells treated with RGD-FasL the AI was higher than that of FasL-treated cells,while in U343 cells the result was on the contrary. The expressions of Caspase-8/9/3,RANKL,JNK2 were increased after treating with RGD-FasL,while the expression of Bcl-2 was decreased obviously,suggesting RGD-FasL might pass the apoptosis signal through Caspase activation. Conclusion Recombined human RGD-FasL could induce apoptosis in glioma cell lines U138/U373/U343. The underlying mechanism may be relevant to the mRNA expressions of their receptors and the release of Caspase-8/9/3 and Bcl-2.

Construction,expression,and Purification of RGD-FasL and Analysis of Its Activities

Construction, Expression, Purification and Polyclonal Antibody Preparation of Fas Extracellular Region Gene

Efficient expression and primary purification of 6-his tagged human Fas ligand in Dictyostelium discoideum

[Construction of Recombinant GST-RCAS1 Fusion Gene and Its Expression in E. Coli].

Production, purification and cytotoxity of soluble human Fas ligand expressed by Escherichia coli and Dictyostelium discoideum

The expression and application of human Fas ligand in E.coli

Anti-tumor Activities of Recombined Human RGD-FasL Against Three Glioma Cell Lines U138/U373/U343

Construction of FasL Sirna Expression Vector and Its Expression in Lung Cancer Cell Line A549

Successful Construction and Stable Expression of an Anti-Cd45ra Scfv–egfp Fusion Protein in Chinese Hamster Ovary Cells

The Construction of Anti-EGFR Single Chain Variable Fragment Fused with Gelonin Toxin Prokaryotic Expressing Plasmid and the Study of Its Anti-tumor Effects

Purification and Characterization of Rgd Tumor-Homing Peptide Conjugated Human Tumor Necrosis Factor Alpha Over-Expressed in Escherichia Coli

High-level expression and purification of a nonmitogenic form of human acidic fibroblast growth factor in Escherichia coli.

Construction and Expression of Anti-Glioma Single-Chain Fv/human Tumor Necrosis Factor Α Fusion Gene

Construction, Expression and Functional Studies of Recombinant Human L-ficolin

RGD-FasL Induces Apoptosis of Pituitary Adenoma Cells.

[Construction and Expression of an Anti-Gd2,scfv-il-2 Fusion Protein Gene].

Construction of Replication-defective Adenovirus Vector Containing Human Fas Ligand Gene and Its Expression

Gene Construction, Expression and Activity Identification of Recombinant Anti-Her2 ScFv/FDT/caspase-6

Cloning and Expression of Rat CTLA4-FasL Fusion Gene and Its Biological Activity in Vitro

Cloning expression and purification of the polypeptide with abundant T cell epitopes from tumor fibroblast activation protein

Prokaryotic Expression, Purification of a Novel Candidate Tumor Suppressor Gene FUS1 and Characterization of Its Polyclonal Antibodies